semaglutide shortage update As of February 21, 2025, the FDA updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Semaglutide and Tirzepatide No Longer

Insert the spray nozzle into the nostril, angling the tip toward the lateral nasal wall (the outer wall of the nose), not toward the septum (center wall)

they should not be withheld solely because of fatty liver

Tirzepatide is a prescription medication approved by the FDA for the treatment of type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (marketed as Zepbound)

10.1034/j.1398-9995.2003.00264.x 17

What is stomach paralysis

Relying on Fad Diets: Falling for the allure of fad diets that promise quick weight loss can be counterproductive